Post Profile






SmartPractice donates $50,000 toward TGen liquid biopsy research

(The Translational Genomics Research Institute) In support of efforts to find better ways of diagnosing and monitoring breast cancer patients, SmartPractice today donated $50,000 to the Translational Genomics Research Institute (TGen). This SmartPractice gift will support TGen's development of 'liquid biopsies,' which are simple, low-cost, non-invasive blood tests that can help clinicians more accurately treat patients with cancer.
read more

share

Related Posts


'Liquid biopsy' promotes precision medicine by tracking patient's cancer

Academics / General Science : Science Codex

PHOENIX, Ariz. -- Nov. 4, 2015 -- A team of researchers, including scientists from the Translational Genomics Research Institute (TGen), has reported that analyzing circulating tumor DNA (ctDNA) can track how a patient's cancer evol...

Hope Through Hollis Fund at TGen supports innovative childhood brain cancer research

Academics / Biology : EurekAlert: Biology

(The Translational Genomics Research Institute) In an effort to 'move the needle' toward improved treatments for a rare form of childhood brain cancer known as DIPG, Shane and Shawnee Doherty have donated $30,000 in memory of their ...

Mayo Clinic – TGen Study Role Testosterone May Play in Triple Negative Breast Cancer

Health : Mayo Clinic News Blog

Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer?  That’s a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...

‘Liquid biopsy’ Promotes Precision Medicine by Tracking Patient’s Cancer

Health : Mayo Clinic News Blog

Circulating tumor DNA in blood could inform physicians on best treatments for individual patients PHOENIX, Ariz. - Nov. 4, 2015 - A team of researchers, including scientists from the Translational Genomics Research Institute (TGen),...

Breast cancer patients benefit from treatments tailored specifically for their tumor types

Health : Medical News Today

The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when their tr...

Comments


Copyright © 2016 Regator, LLC